{
    "clinical_study": {
        "@rank": "144490", 
        "arm_group": [
            {
                "arm_group_label": "no antibiotic prophylaxis", 
                "arm_group_type": "Active Comparator", 
                "description": "These patients are in no antibiotic prophylaxis group will not be administered antibiotic prophylactically."
            }, 
            {
                "arm_group_label": "second-generation cephalosporin", 
                "arm_group_type": "Active Comparator", 
                "description": "These patients are in antibiotic prophylaxis group will be administered second-generation cephalosporin prophylactically."
            }
        ], 
        "brief_summary": {
            "textblock": "Peroral Endoscopic Myotomy (POEM) is a novel, promising endoscopic technique for achalasia\n      because it is safer and more effective than traditional Heller's myotomy. However, the issue\n      of antibiotic prophylaxis in POEM has evoked considerable controversy recently. Therefore,\n      we conduct this study to elucidate the status of POEM-related bacteremia and procalcitonin\n      levels in order to preliminary observe whether antibiotic prophylaxis is needed."
        }, 
        "brief_title": "Bacteremia and Procalcitonin Levels in Peroral Endoscopic Myotomy for Achalasia", 
        "completion_date": {
            "#text": "August 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Esophageal Achalasia", 
        "condition_browse": {
            "mesh_term": [
                "Bacteremia", 
                "Esophageal Achalasia"
            ]
        }, 
        "detailed_description": {
            "textblock": "Objective: To elucidate the status of POEM-related bacteremia and procalcitonin levels in\n      order to preliminary observe whether antibiotic prophylaxis is needed.\n\n      Interventions: Patients with achalasia diagnosed by symptoms, endoscopy and barium swallow\n      eligible for POEM are randomized to either use antibiotic prophylactically or not.\n\n      Main outcome measurements: Blood culture positive incidence; secondary outcomes are\n      procalcitonin levels, C-reactive protein levels, white blood cell counts and so on."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Clinical diagnosis of esophageal achalasia\n\n          -  Ready to have the treatment as POEM and no contraindication of POEM\n\n          -  Ability to get informed consent\n\n        Exclusion Criteria:\n\n          -  Patients who had indications for antibiotic prophylaxis as determined by   the\n             American Society for Gastrointestinal Endoscopy\n\n          -  Patients who had received antibiotics for any reason within the previous 7days\n\n          -  Patients who had possible signs of any infection at the time of the procedure\n\n          -  Patients who had chronic inflammatory diseases need hormonotherapy : such as\n             rheumatic arthritis or inflammatory bowel diseases."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 20, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01750385", 
            "org_study_id": "B2012-089"
        }, 
        "intervention": [
            {
                "arm_group_label": "no antibiotic prophylaxis", 
                "description": "These patients are in no antibiotic prophylaxis group will not be administered antibiotic prophylactically.", 
                "intervention_name": "no antibiotic prophylaxis", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "second-generation cephalosporin", 
                "description": "These patients are in antibiotic prophylaxis group will be administered second-generation cephalosporin prophylactically.", 
                "intervention_name": "second-generation cephalosporin", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Anti-Bacterial Agents", 
                "Cephalosporins", 
                "Antibiotics, Antitubercular"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Esophageal Achalasia", 
            "antibiotic prophylaxis", 
            "blood culture", 
            "procalcitonin levels"
        ], 
        "lastchanged_date": "December 12, 2012", 
        "number_of_arms": "2", 
        "official_title": "Bacteremia and Procalcitonin Levels in Peroral Endoscopic Myotomy for Achalasia", 
        "other_outcome": {
            "description": "To observe the changes of temperature, heart rate, respiratory rate, white blood cell counts, neutrophile granulocyte counts in perioperative period.", 
            "measure": "clinical manifestation", 
            "safety_issue": "Yes", 
            "time_frame": "during hospital stay and up to 1 week"
        }, 
        "overall_official": {
            "affiliation": "Fudan University", 
            "last_name": "Ping-Hong Zhou, M.D,PhD", 
            "role": "Study Director"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "To compare the positive incidence of blood cultures between antibiotic prophylaxis and no antibiotic prophylaxis.", 
            "measure": "Blood culture positive incidence", 
            "safety_issue": "Yes", 
            "time_frame": "after 12 hours of POEM"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01750385"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "To observe the changes of procalcitonin levels after POEM in which no antibiotic is administered.\nTo compare the procalcitonin levels between antibiotic prophylaxis and no antibiotic prophylaxis.", 
            "measure": "procalcitonin level", 
            "safety_issue": "Yes", 
            "time_frame": "after 12 hours of POEM"
        }, 
        "source": "Shanghai Zhongshan Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Shanghai Zhongshan Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "December 2012"
    }
}